Hydrogen chloride - 1-butanol solution

~3 M in 1-butanol, for GC derivatization, LiChropur

CAS Number:
Beilstein/REAXYS Number:
MDL number:
PubChem Substance ID:

Quality Level


for GC derivatization



reaction suitability

reagent type: derivatization reagent
reaction type: Acylations


~3 M in 1-butanol


gas chromatography (GC): suitable


0.87 g/mL at 20 °C

storage temp.


SMILES string




InChI key


General description

Acylation, an alternative to silylation, is the conversion of compounds that contain active hydrogens (-OH, -SH and -NH) into esters, thioesters, and amides through the action of a carboxylic acid or derivative. The presence of a carbonyl group adjacent to the halogenated carbons enhances electron capture detector (ECD) response. Acylation has many benefits:
  • It improves the stability of compounds by protecting unstable groups.
  • It may confer volatility on substances such as carbohydrates or amino acids, which have so many polar groups that they are non-volatile and normally decompose on heating.
  • It assists in separations not possible with underivatized compounds.
  • Compounds are detectable at very low levels with an ECD.

Hydrogen chloride-1-butanol is a reagent utilized to form fragmentation-directing derivatives for GC/MS analysis.


Hydrogen chloride - 1-butanol solution has been used for butylation of amino acids during blood sample analysis for determination of ethylenediaminetetraacetic acid using mass spectrometry.

Other Notes

Reagent for the esterification of amino acids and carnites for GC-MS analysis

Legal Information

LiChropur is a trademark of Merck KGaA, Darmstadt, Germany

Signal Word


Personal Protective Equipment

dust mask type N95 (US),Eyeshields,Gloves


UN 2920 3(8) / PGII

WGK Germany


M S Rashed et al.
Clinical chemistry, 43(7), 1129-1141 (1997-07-01)
Metabolic profiling of amino acids and acylcarnitines from blood spots by automated electrospray tandem mass spectrometry (ESI-MS/MS) is a powerful diagnostic tool for inborn errors of metabolism. New approaches to sample preparation and data interpretation have helped establish the methodology...
Akihiro Hideno et al.
Bioresource technology, 132, 64-70 (2013-02-12)
The effects of adding trace acids in ethanol based organosolv treatment were investigated to increase the enzymatic digestibility of Japanese cypress. A high glucose yield (60%) in the enzymatic hydrolysis was obtained by treating the sample at 170 °C for...
Daniely Cornélio Favarin et al.
Mediators of inflammation, 2013, 164202-164202 (2013-03-28)
Acute lung injury (ALI) is characterized by alveolar edema and uncontrolled neutrophil migration to the lung, and no specific therapy is still available. Ellagic acid, a compound present in several fruits and medicinal plants, has shown anti-inflammatory activity in several...
Yan-Ling Li et al.
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 38(6), 817-820 (2013-05-31)
To prepare the new traditional Chinese medicine preparation--pH-dependent brevisapin colon-specific tablets, and investigate its in vitro release, in order to discuss the feasibility of preparing colon-targeted traditional Chinese medicines. With scutellarin, the active ingredient in brevisapin, as the evaluation index...
J Marwaha et al.
Experimental parasitology, 134(1), 12-17 (2013-02-16)
Intestinal cestodes with complex life cycles have to pass through the acid stomach lumen of their vertebrate host(s) in order to reach their preferred site of development. The cestode's tegument is the only organ in constant contact with this hostile...

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.